Your browser doesn't support javascript.
loading
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
Robichaux, Jacqulyne P; Elamin, Yasir Y; Tan, Zhi; Carter, Brett W; Zhang, Shuxing; Liu, Shengwu; Li, Shuai; Chen, Ting; Poteete, Alissa; Estrada-Bernal, Adriana; Le, Anh T; Truini, Anna; Nilsson, Monique B; Sun, Huiying; Roarty, Emily; Goldberg, Sarah B; Brahmer, Julie R; Altan, Mehmet; Lu, Charles; Papadimitrakopoulou, Vassiliki; Politi, Katerina; Doebele, Robert C; Wong, Kwok-Kin; Heymach, John V.
Afiliação
  • Robichaux JP; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Elamin YY; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tan Z; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Carter BW; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang S; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Li S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chen T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Poteete A; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Estrada-Bernal A; University of Colorado Cancer Center, Aurora, CO, USA.
  • Le AT; University of Colorado Cancer Center, Aurora, CO, USA.
  • Truini A; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
  • Nilsson MB; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sun H; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Roarty E; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Goldberg SB; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
  • Brahmer JR; Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Altan M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Lu C; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Papadimitrakopoulou V; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Politi K; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Doebele RC; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
  • Wong KK; Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Heymach JV; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
Nat Med ; 2024 Aug 20.
Article em En | MEDLINE | ID: mdl-39164519
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article